Hype, Promise, and Reality: Orthopedic Use of Biologics in 2019 (AANA19)-Questions and Answers_ Hype, Promise, and Reality_ Orthopedic Use of Biologics in 2019-Dr. Stephen C. Weber, M.D.

Questions and Answers_ Hype, Promise, and Reality_ Orthopedic Use of Biologics in 2019-Dr. Stephen C. Weber, M.D.

Video Transcription

Video Summary

The discussion revolves around billing and insurance issues related to PRP and stem cell procedures, emphasizing these treatments are largely not covered by insurance except occasionally under workers' comp. Advanced beneficiary notices (ABNs) are recommended for government patients to manage charges. Office and OR-based procedures differ mainly in billing and coding complexities, especially with government payers bundling services. The effectiveness of these treatments remains uncertain, with ongoing studies and cautious patient communication advised. Providers share varied protocols for PRP injections in osteoarthritis, often favoring multiple spaced treatments and combining with hyaluronic acid. Overall, transparency and managing patient expectations are stressed.

Asset Caption

Instructional Course Lecture: Hype, Promise, and Reality: Orthopedic Use of Biologics in 2019

Keywords

PRP billing

stem cell insurance coverage

advanced beneficiary notices

osteoarthritis PRP protocols

patient communication transparency